Education
About Us
Working with TipRanks
Follow Us
Lytix Biopharma AS (DE:6BG)
:6BG
| Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|
| Income Statement | ||||
| Total Revenue | ||||
| Gross Profit | - | - | - | - |
| Operating Income | $ -65.70M | $ -48.02M | $ -42.37M | $ -32.96M |
| EBITDA | $ -55.92M | $ -48.05M | $ -42.09M | $ -32.96M |
| Net Income | $ -56.01M | $ -48.05M | $ -42.09M | $ -32.41M |
| Balance Sheet | ||||
| Cash & Short-Term Investments | $ ― | $ ― | $ ― | $ ― |
| Total Assets | $ 152.02M | $ 202.96M | $ 32.62M | $ 17.43M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ -145.16M | $ -197.28M | $ -28.45M | $ -12.80M |
| Total Liabilities | $ 16.89M | $ 13.34M | $ 12.73M | $ 3.85M |
| Stockholders' Equity | $ ― | $ ― | $ ― | $ ― |
| Cash Flow | ||||
| Free Cash Flow | $ -52.26M | $ -44.90M | $ -24.35M | $ -36.82M |
| Operating Cash Flow | $ -52.10M | $ -44.90M | $ -24.35M | $ -36.82M |
| Investing Cash Flow | ||||
| Financing Cash Flow |
Lytix Biopharma AS Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.